Id-1 and Id-2 genes and products as markers of epithelial cancer

Desprez, Pierre-Yves; Campisi, Judith

Advanced Search OptionsAdvanced Search queries use a traditional Term Search. For more info, see our FAQ.

All Fields:

Patent Title:

Abstract:

Assignee:

Inventor(s):

Patent Number:

Patent Classification (CPC):

All Classifications
A - human necessities
A01 - agriculture
A21 - baking
A22 - butchering
A23 - foods or foodstuffs
A24 - tobacco
A41 - wearing apparel
A42 - headwear
A43 - footwear
A44 - haberdashery
A45 - hand or travelling articles
A46 - brushware
A47 - furniture
A61 - medical or veterinary science
A62 - life-saving
A63 - sports
A99 - subject matter not otherwise provided for in this section
B - performing operations
B01 - physical or chemical processes or apparatus in general
B02 - crushing, pulverising, or disintegrating
B03 - separation of solid materials using liquids or using pneumatic tables or jigs
B04 - centrifugal apparatus or machines for carrying-out physical or chemical processes
B05 - spraying or atomising in general
B06 - generating or transmitting mechanical vibrations in general
B07 - separating solids from solids
B08 - cleaning
B09 - disposal of solid waste
B21 - mechanical metal-working without essentially removing material
B22 - casting
B23 - machine tools
B24 - grinding
B25 - hand tools
B26 - hand cutting tools
B27 - working or preserving wood or similar material
B28 - working cement, clay, or stone
B29 - working of plastics
B30 - presses
B31 - making articles of paper, cardboard or material worked in a manner analogous to paper
B32 - layered products
B33 - additive manufacturing technology
B41 - printing
B42 - bookbinding
B43 - writing or drawing implements
B44 - decorative arts
B60 - vehicles in general
B61 - railways
B62 - land vehicles for travelling otherwise than on rails
B63 - ships or other waterborne vessels
B64 - aircraft
B65 - conveying
B66 - hoisting
B67 - opening, closing {or cleaning} bottles, jars or similar containers
B68 - saddlery
B81 - microstructural technology
B82 - nanotechnology
B99 - subject matter not otherwise provided for in this section
C - chemistry
C01 - inorganic chemistry
C02 - treatment of water, waste water, sewage, or sludge
C03 - glass
C04 - cements
C05 - fertilisers
C06 - explosives
C07 - organic chemistry
C08 - organic macromolecular compounds
C09 - dyes
C10 - petroleum, gas or coke industries
C11 - animal or vegetable oils, fats, fatty substances or waxes
C12 - biochemistry
C13 - sugar industry
C14 - skins
C21 - metallurgy of iron
C22 - metallurgy
C23 - coating metallic material
C25 - electrolytic or electrophoretic processes
C30 - crystal growth
C40 - combinatorial technology
C99 - subject matter not otherwise provided for in this section
D - textiles
D01 - natural or man-made threads or fibres
D02 - yarns
D03 - weaving
D04 - braiding
D05 - sewing
D06 - treatment of textiles or the like
D07 - ropes
D10 - indexing scheme associated with sublasses of section d, relating to textiles
D21 - paper-making
D99 - subject matter not otherwise provided for in this section
E - fixed constructions
E01 - construction of roads, railways, or bridges
E02 - hydraulic engineering
E03 - water supply
E04 - building
E05 - locks
E06 - doors, windows, shutters, or roller blinds in general
E21 - earth drilling
E99 - subject matter not otherwise provided for in this section
F - mechanical engineering
F01 - machines or engines in general
F02 - combustion engines
F03 - machines or engines for liquids
F04 - positive - displacement machines for liquids
F05 - indexing schemes relating to engines or pumps in various subclasses of classes f01-f04
F15 - fluid-pressure actuators
F16 - engineering elements and units
F17 - storing or distributing gases or liquids
F21 - lighting
F22 - steam generation
F23 - combustion apparatus
F24 - heating
F25 - refrigeration or cooling
F26 - drying
F27 - furnaces
F28 - heat exchange in general
F41 - weapons
F42 - ammunition
F99 - subject matter not otherwise provided for in this section
G - physics
G01 - measuring
G02 - optics
G03 - photography
G04 - horology
G05 - controlling
G06 - computing
G07 - checking-devices
G08 - signalling
G09 - education
G10 - musical instruments
G11 - information storage
G12 - instrument details
G16 - information and communication technology [ict] specially adapted for specific application fields
G21 - nuclear physics
G99 - subject matter not otherwise provided for in this section
H - electricity
H01 - basic electric elements
H02 - generation
H03 - basic electronic circuitry
H04 - electric communication technique
H05 - electric techniques not otherwise provided for
H99 - subject matter not otherwise provided for in this section
Y - new / cross sectional technologies
Y02 - technologies or applications for mitigation or adaptation against climate change
Y04 - information or communication technologies having an impact on other technology areas
Y10 - technical subjects covered by former uspc

More Options ...

Title: Id-1 and Id-2 genes and products as markers of epithelial cancer

Abstract

A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.

Inventors:

Desprez, Pierre-Yves ^[1]; Campisi, Judith ^[2]

El Cerrito, CA
Berkeley, CA

Issue Date:: Tue Oct 04 00:00:00 EDT 2011

Research Org.:: Univ. of California (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1029286

Patent Number(s):: 8030012

Application Number:: 11/390,682

Assignee:: OAK

Patent Classifications (CPCs):: A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS

Show more

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00 - Antineoplastic agents

C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
C12Q1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
C12Q1/6886 - for cancer
C12Q2600/106 - Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
C12Q2600/156 - Polymorphic or mutational markers
C12Q2600/158 - Expression markers

G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N33/57407 - {Specifically defined cancers}
G01N33/57415 - {of breast}
G01N33/5743 - {of skin, e.g. melanoma}
G01N33/57434 - {of prostate}
G01N33/57492 - {involving compounds localized on the membrane of tumor or cancer cells}

Show less

DOE Contract Number:: AC03-76SF00098; AC02-05CH11231

Resource Type:: Patent

Country of Publication:: United States

Language:: English

Subject:: 60 APPLIED LIFE SCIENCES

Citation Formats


                    Desprez, Pierre-Yves, and Campisi, Judith. Id-1 and Id-2 genes and products as markers of epithelial cancer.  United States: N. p., 2011. 
        Web.

Copy to clipboard


                    Desprez, Pierre-Yves, & Campisi, Judith. Id-1 and Id-2 genes and products as markers of epithelial cancer.  United States.

Copy to clipboard


                    Desprez, Pierre-Yves, and Campisi, Judith. Tue .  
        "Id-1 and Id-2 genes and products as markers of epithelial cancer".  United States.  https://www.osti.gov/servlets/purl/1029286.

Copy to clipboard


                    
@article{osti_1029286,

  title        = {Id-1 and Id-2 genes and products as markers of epithelial cancer},

  author       = {Desprez, Pierre-Yves and Campisi, Judith},

  abstractNote = {A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {Tue Oct 04 00:00:00 EDT 2011},

  month        = {Tue Oct 04 00:00:00 EDT 2011}

}

Copy to clipboard

Patent:

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Id-1 and Id-2 Proteins as Molecular Markers for Human Prostate Cancer Progression
journal, March 2004

Coppe, Jean-Philippe; Itahana, Yoko; Moore, Dan H.
Clinical Cancer Research, Vol. 10, Issue 6
https://doi.org/10.1158/1078-0432.CCR-03-0933

Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer
journal, March 2003

Schoppmann, Sebastian F.; Schindl, Monika; Bayer, Guenther
International Journal of Cancer, Vol. 104, Issue 6
https://doi.org/10.1002/ijc.11009

The Id proteins: targets for inhibiting tumor cells and their blood supply
journal, October 2001

Benezra, Robert
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Vol. 1551, Issue 2
https://doi.org/10.1016/S0304-419X(01)00028-2

Interphase cytogenetics and comparative genomic hybridization of human epithelial cancers and precursor lesions
journal, October 1997

van Dekken, H.; Rosenberg, Carla; Krijtenburg, Pieter J.
Histochemistry and Cell Biology, Vol. 108, Issue 4-5
https://doi.org/10.1007/s004180050182

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis
journal, October 2003

Fong, S.; Itahana, Y.; Sumida, T.
Proceedings of the National Academy of Sciences, Vol. 100, Issue 23
https://doi.org/10.1073/pnas.2230238100

Over Expression of ID-1 in Prostate Cancer
journal, June 2002

Ouyang, X. S.; Wang, X.; Lee, D. T. W.
Journal of Urology, Vol. 167, Issue 6
https://doi.org/10.1016/S0022-5347(05)65044-6

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
journal, September 2005

Straume, O.; Akslen, L. A.
British Journal of Cancer, Vol. 93, Issue 8
https://doi.org/10.1038/sj.bjc.6602792

Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma
journal, April 2001

Takai, Noriyuki; Miyazaki, Tami; Fujisawa, Kayo
Cancer Letters, Vol. 165, Issue 2
https://doi.org/10.1016/S0304-3835(01)00433-5

Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat
journal, June 2001

Ouyang, X. S.
Carcinogenesis, Vol. 22, Issue 6
https://doi.org/10.1093/carcin/22.6.965

Overexpression of the Helix–Loop–Helix protein Id2 blocks T cell development at multiple stages
journal, June 1999

Morrow, Maureen A.; Mayer, Elizabeth W.; Perez, Cesar A.
Molecular Immunology, Vol. 36, Issue 8
https://doi.org/10.1016/S0161-5890(99)00071-1

Gene expression profiling predicts clinical outcome of prostate cancer
journal, March 2004

Glinsky, Gennadi V.; Glinskii, Anna B.; Stephenson, Andrew J.
Journal of Clinical Investigation, Vol. 113, Issue 6
https://doi.org/10.1172/JCI20032

ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value
journal, January 2003

Vandesompele, Jo; Edsjö, Anders; De Preter, Katleen
Oncogene, Vol. 22, Issue 3
https://doi.org/10.1038/sj.onc.1206148

Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1.
journal, June 1995

Desprez, P. Y.; Hara, E.; Bissell, M. J.
Molecular and Cellular Biology, Vol. 15, Issue 6
https://doi.org/10.1128/MCB.15.6.3398

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
journal, November 2007

Yuen, H-F; Chan, Y-P; Chan, K-K
British Journal of Cancer, Vol. 97, Issue 10
https://doi.org/10.1038/sj.bjc.6604035

Systemic Gene Delivery Expands the Repertoire of Effective Antiangiogenic Agents
journal, May 1999

Liu, Yong; Thor, Ann; Shtivelman, Emma
Journal of Biological Chemistry, Vol. 274, Issue 19
https://doi.org/10.1074/jbc.274.19.13338

Id-1 and Id-2 Are Overexpressed in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis
journal, September 1999

Maruyama, Haruhisa; Kleeff, Jörg; Wildi, Stefan
The American Journal of Pathology, Vol. 155, Issue 3, p. 815-822
https://doi.org/10.1016/S0002-9440(10)65180-2

Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer
journal, September 2007

Forootan, Shiva S.; Wong, Yong-Chuan; Dodson, Andrew
Human Pathology, Vol. 38, Issue 9
https://doi.org/10.1016/j.humpath.2007.02.011

Similar Records in DOE Patents and OSTI.GOV collections:

Id-1 and Id-2 genes and products as markers of epithelial cancer

Patent Desprez, Pierre-Yves [El Cerrito, CA]; Campisi, Judith [Berkeley, CA]

A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.
Full Text Available
Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma

Patent Desprez, Pierre-Yves; Campisi, Judith

A method for treatment and amelioration of breast, cervical, ovarian, endometrial, squamous cells, prostate cancer and melanoma in a patient comprising targeting Id-1 or Id-2 gene expression with a delivery vehicle comprising a product which modulates Id-1 or Id-2 expression.
Full Text Available
Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma

Patent Desprez, Pierre-Yves; Campisi, Judith

A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.
Full Text Available
Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

Patent Hu, Zhi [El Cerrito, CA]; Kuo, Wen-Lin [San Ramon, CA]; Neve, Richard M [San Mateo, CA]; ...

Amplification of the ANXA9 gene in human chromosomal region 1q21 in epithelial cancers indicates a likelihood of both in vivo drug resistance and metastasis, and serves as a biomarker indicating these aspects of the disease. ANXA9 can also serve as a therapeutic target. Interfering RNAs (iRNAs) (such as siRNA and miRNA) and shRNA adapted to inhibit ANXA9 expression, when formulated in a therapeutic composition, and delivered to cells of the tumor, function to treat the epithelial cancer.
Full Text Available
Human AZU-1 gene, variants thereof and expressed gene products

Patent Chen, Huei-Mei; Bissell, Mina

A human AZU-1 gene, mutants, variants and fragments thereof. Protein products encoded by the AZU-1 gene and homologs encoded by the variants of AZU-1 gene acting as tumor suppressors or markers of malignancy progression and tumorigenicity reversion. Identification, isolation and characterization of AZU-1 and AZU-2 genes localized to a tumor suppressive locus at chromosome 10q26, highly expressed in nonmalignant and premalignant cells derived from a human breast tumor progression model. A recombinant full length protein sequences encoded by the AZU-1 gene and nucleotide sequences of AZU-1 and AZU-2 genes and variant and fragments thereof. Monoclonal or polyclonal antibodies specific tomore » « less
Full Text Available

Similar Records

Title: Id-1 and Id-2 genes and products as markers of epithelial cancer

Abstract

Citation Formats

Id-1 and Id-2 Proteins as Molecular Markers for Human Prostate Cancer Progression journal, March 2004

Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer journal, March 2003

The Id proteins: targets for inhibiting tumor cells and their blood supply journal, October 2001

Interphase cytogenetics and comparative genomic hybridization of human epithelial cancers and precursor lesions journal, October 1997

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis journal, October 2003

Over Expression of ID-1 in Prostate Cancer journal, June 2002

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma journal, September 2005

Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma journal, April 2001

Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat journal, June 2001

Overexpression of the Helix–Loop–Helix protein Id2 blocks T cell development at multiple stages journal, June 1999

Gene expression profiling predicts clinical outcome of prostate cancer journal, March 2004

ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value journal, January 2003

Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. journal, June 1995

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma journal, November 2007

Systemic Gene Delivery Expands the Repertoire of Effective Antiangiogenic Agents journal, May 1999

Id-1 and Id-2 Are Overexpressed in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis journal, September 1999

Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer journal, September 2007

Id-1 and Id-2 Proteins as Molecular Markers for Human Prostate Cancer Progression
journal, March 2004

Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer
journal, March 2003

The Id proteins: targets for inhibiting tumor cells and their blood supply
journal, October 2001

Interphase cytogenetics and comparative genomic hybridization of human epithelial cancers and precursor lesions
journal, October 1997

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis
journal, October 2003

Over Expression of ID-1 in Prostate Cancer
journal, June 2002

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
journal, September 2005

Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma
journal, April 2001

Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat
journal, June 2001

Overexpression of the Helix–Loop–Helix protein Id2 blocks T cell development at multiple stages
journal, June 1999

Gene expression profiling predicts clinical outcome of prostate cancer
journal, March 2004

ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value
journal, January 2003

Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1.
journal, June 1995

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
journal, November 2007

Systemic Gene Delivery Expands the Repertoire of Effective Antiangiogenic Agents
journal, May 1999

Id-1 and Id-2 Are Overexpressed in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis
journal, September 1999

Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer
journal, September 2007